Abstract
Purpose of the Review Three Janus kinase (JAK) inhibitors are approved for rheumatoid arthritis (RA) with a fourth awaiting approval. Multiple clinica......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
